Sign up to save your podcasts
Or
Share Latest Clinical Data for First-line Maintenance and R/R Small-Cell Lung Cancer (SCLC)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Latest Clinical Data for First-line Maintenance and R/R Small-Cell Lung Cancer (SCLC)
Welcome to the Oncology Brothers podcast! In this episode, we kick off a three-part CME series focused on small cell lung cancer (SCLC). Joined by Dr. Hossein Borghaei, Chief of Thoracic Oncology at the Fox Chase Cancer Center. Together they dived into the evolving treatment landscape for SCLC, highlighting recent advancements and data from ASCO 2025.
Episode Highlights:
• Overview of the current standard of care for limited and extensive-stage SCLC.
• Discussion on the role of concurrent chemoradiation therapy and the new standard of care involving immunotherapy.
• Insights into the use of lurbinectedin in maintenance therapy and its impact on overall survival.
• Exploration of the promising results from the DeLLphi study on tarlatamab, a bispecific antibody, and its implications for treatment.
• The importance of patient selection and managing side effects in treatment decisions.
Join us as we navigate the complexities of SCLC treatment and look forward to future advancements that may improve patient outcomes.
Accreditation/Credit Designation
Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Acknowledgment of Commercial Support
This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.
Link to gain CME credits from this activity:
https://www.gotoper.com/courses/breaking-down-the-latest-clinical-data-for-first-line-maintenance-and-rr-sclc
Follow us on social media:
• X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/
#OncologyBrothers #SmallCellLungCancer #CME #ASCO2025 #LungCancer #Immunotherapy #CancerTreatment
View all episodes
By Oncology Brothers
4.8
3939 ratings
Welcome to the Oncology Brothers podcast! In this episode, we kick off a three-part CME series focused on small cell lung cancer (SCLC). Joined by Dr. Hossein Borghaei, Chief of Thoracic Oncology at the Fox Chase Cancer Center. Together they dived into the evolving treatment landscape for SCLC, highlighting recent advancements and data from ASCO 2025.
Episode Highlights:
• Overview of the current standard of care for limited and extensive-stage SCLC.
• Discussion on the role of concurrent chemoradiation therapy and the new standard of care involving immunotherapy.
• Insights into the use of lurbinectedin in maintenance therapy and its impact on overall survival.
• Exploration of the promising results from the DeLLphi study on tarlatamab, a bispecific antibody, and its implications for treatment.
• The importance of patient selection and managing side effects in treatment decisions.
Join us as we navigate the complexities of SCLC treatment and look forward to future advancements that may improve patient outcomes.
Accreditation/Credit Designation
Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Acknowledgment of Commercial Support
This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.
Link to gain CME credits from this activity:
https://www.gotoper.com/courses/breaking-down-the-latest-clinical-data-for-first-line-maintenance-and-rr-sclc
Follow us on social media:
• X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/
#OncologyBrothers #SmallCellLungCancer #CME #ASCO2025 #LungCancer #Immunotherapy #CancerTreatment
More shows like Oncology Brothers: Practice-Changing Cancer Discussions
View all
NEJM This Week
320 Listeners
Journal of Clinical Oncology (JCO) Podcast
42 Listeners
Research To Practice | Oncology Videos
111 Listeners
JAMA Clinical Reviews
501 Listeners
ASCO Daily News
60 Listeners
Core IM | Internal Medicine Podcast
1,110 Listeners
OncoPharm
182 Listeners
ASCO Guidelines
46 Listeners
OncLive® On Air
22 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
350 Listeners
Lung Cancer Considered
27 Listeners
The Passive Income MD Podcast
277 Listeners
Oncology Today with Dr Neil Love
60 Listeners
Two Onc Docs
181 Listeners
Blood Cancer Talks
48 Listeners